Publications in peer-reviewed journals:
Prenatal Exposure to Antiseizure Medication and Incidence of Childhood- and Adolescence-Onset Psychiatric Disorders. Dreier JW, Bjørk MH, Alvestad S, Gissler M, Igland J, Leinonen MK, Sun Y, Zoega H, Cohen JM, Furu K, Tomson T, Christensen J. JAMA Neurol. 2023 Apr 17:e230674. Online ahead of print.
Benefits and Risks of Periconceptional Folic Acid Supplementation-Reply. Vegrim HM, Tomson T, Bjørk MH. JAMA Neurol. 2023 Apr 1;80(4):421-422.
Cancer Risk in Children of Mothers With Epilepsy and High-Dose Folic Acid Use During Pregnancy. Vegrim HM, Dreier JW, Alvestad S, Gilhus NE, Gissler M, Igland J, Leinonen MK, Tomson T, Sun Y, Zoega H, Christensen J, Bjørk MH. JAMA Neurol. 2022 Nov 1;79(11):1130-1138.
Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability. Bjørk MH, Zoega H, Leinonen MK, Cohen JM, Dreier JW, Furu K, Gilhus NE, Gissler M, Hálfdánarson Ó, Igland J, Sun Y, Tomson T, Alvestad S, Christensen J. JAMA Neurol 2022 Jul 1;79(7):672-681.
Prenatal exposure to valproate and risk of congenital malformations—Could we have known earlier?—A population-based cohort study. Christensen J, Trabjerg B, Sun Y, Gilhus NE, Bjørk MH, Tomson T, Dreier JW. Epilepsia. 2021 Sep 28. doi: 10.1111.
Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy. Tomson T, Battino D, Bromley R, Kochen S, Meador K, Pennell P, Thomas SV. Epileptic Disord. 2019 Nov 29.
Abstracts and presentations:
Prenatal Exposure to Antiseizure Medication and Birth Weight Outcomes. Christensen et al. Platform presentation at the American Epilepsy Society meeting 2022.
Maternal Epilepsy, Prenatal Exposure to High-Dose Folic Acid, and Risk of Childhood Cancer: A Nordic Registry-Based Cohort Study. Vegrim et al. Poster presentation at the American Epilepsy Society meeting 2021.
Folic acid supplementation and risk of neurodevelopmental disorders in children prenatally exposed to anti-seizure medication. SCAN-AED: a Nordic population-based cohort study. Alvestad et al. Poster presentation at the American Epilepsy Society meeting 2021.
Prenatal antiseizure medication exposure and risk of autism and intellectual disability. SCAN-AED: a Nordic cohort study. Bjørk MH, Zoega H, Leinonen MK, Cohen JM, Dreier JW, Furu K, Gilhus NE, Gissler M, Hálfdánarson Ó, Igland J, Sun Y, Tomson T, Alvestad S, Christensen J. Oral presentation at the 7th Congress of the European Academy of Neurology, 19-22 June 2021.
Prenatal exposure to antiseizure medication and the full spectrum of diagnosed psychiatric disorders: A SCAN-AED study. Dreier JW, Bjørk MH, Alvestad S, Gissler M, Igland J, Leinonen MK, Sun Y, Cohen JM, Furu K, Zoega H, Tomson T, Christensen J. Oral presentation at the 7th Congress of the European Academy of Neurology, 19-22 June 2021.
Autism and intellectual disability in children exposed to valproate, lamotrigine, carbamazepine and levetiracetam. Bjørk MH, Zoega H, Leinonen M, Alvestad S, Cohen JM, Dreier JW, Furu K, Gilhus NE, Gissler M, Hálfdánarson Ó, Igland J, Sun Y, Tomson T, Christensen J. Abstract for the 6th Congress of the European Academy of Neurology, 23-26 May 2020.
SCAN-AED summary. Part of a joint position paper from the Danish Epidemiological Society, the Danish Society for Pharmacoepidemiology, and Statistics Denmark, 2019.
Scandinavian multi-registry study of antiepileptic drug teratogenicity: the SCAN-AED study. Bjørk MH, Alvestad S, Gilhus NE, Dreier JW, Christensen J, Gissler M, Leinonen M, Tomson T. Poster at the 5th Congress of European Academy of Neurology, Oslo June 30 – July 2, 2019.
Scandinavian multi-registry study of antiepileptic drug teratogenicity: the SCAN-AED study. Bjørk MH, Alvestad S, Gilhus NE, Dreier JW, Christensen J, Gissler M, Leinonen M, Tomson T. Oral presentation at the 11th NorPEN Meeting, Oslo 7-9 Nov 2018.